SCB Hosts Webinar with FDA: CBER's Consensus Standards Recognition Program

On Wednesday, February 21, the Standards Coordinating Body (SCB) held a webinar with speakers from the FDA and SCB to introduce and explain the use of the recently published CBER document, “Guidance for Industry: Voluntary Consensus Standards Recognitions Program for Regenerative Medicine Therapies” as well as the initial list of recognized voluntary consensus standards. After the presentations, FDA speakers, including Judy Arcidiacono, Malcolm Moos, and Archana Siddam answered participant questions.

The RMT community can use the information in this webinar to inform their use of voluntary consensus standards in their regulatory submissions.